Recent evidence suggests a beneficial effect of chronically increased LCN2 levels in patients with obesity or type 2 diabetes [48,49], as it assists in counteracting obesity-induced glucose intolerance by reducing appetite and driving beta-cell proliferation [50]. This evidence concerns the gene LCN2 and type 2 diabetes mellitus.